Immunoperoxidase and immunofluorescent staining of Rickettsia rickettsii in skin biopsies: A comparative study

Archives of Pathology and Laboratory Medicine

Volumn 121, Issue 8, 1997, Pages 894-899

  Procop, G W ^a   Burchette Jr , J L ^a   Howell, D N ^a   Sexton, D J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIUM DETECTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; NONHUMAN; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; SKIN BIOPSY; STAINING;

BIOPSY; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; HUMANS; IMMUNOENZYME TECHNIQUES; RICKETTSIA RICKETTSII; ROCKY MOUNTAIN SPOTTED FEVER; SENSITIVITY AND SPECIFICITY; SKIN; SKIN DISEASES, BACTERIAL;

EID: 0030834235     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Walker DH, Raoult D. Rickettsia rickettsii and other spotted fever group rickettsiae (Rocky Mountain spotted fever and other spotted fevers): In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases, New York, NY: Churchill Livingstone; 1995.
2. Woods GL, Gutierrez Y. Diagnostic Pathology of Infectious Diseases. Philadelphia, Pa: Lea & Febiger; 1993.
3. Walker DH. Rocky Mountain spotted fever: a seasonal alert. Clin Infect Dis. 1995;20:111-1117.
4. Hoskins JD. Tick-borne zoonoses: Lyme disease, ehrlichiosis, and Rocky Mountain spotted fever. Semin Vet Med Surg. 1991;6:236-243.
5. Walker DH, Fishbein DB. Epidemiology of rickettsial diseases. Eur J Epidemiol. 1991;7:237-245.
6. Walker DH, Cain BG. The rickettsial plaque: evidence for direct effect of Rickettsia rickettsii. Lab Invest. 1980;43:388-396.
7. Silverman DJ. Rickettsia rickettsii-induced cellular injury of human vascular endothelium in vitro. Infect Immun. 1984;44:545-553.
8. Harrell GT, Aikawa JK. Pathogenesis of circulatory failure in Rocky Mountain spotted fever: alterations in the blood volume and the thiocyanate space at various stage of the disease. Arch Intern Med. 1949;83:331-347.
9. Kaplowitz LG, Fischer JJ, Sparling PF. Rocky Mountain fever: a clinical dilemma. In: Remington JS, Swartz MN, eds. Current Clinical Topics in Infectious Diseases. New York, NY: McCraw Hill International Book Co; 1981;2:89-108.
10. Helmick CG, Bernard KW, D'Angelo LJ. Rocky Mountain spotted fever: clinical, laboratory, and epidemiological features of 262 cases. J Infect Dis. 1984;150:480-488.
11. Davidson MG, Breitschwerdt EB, Walker DH, et al. Vascular permeability and coagulation during Rickettsia rickettsii infection in dogs. Am J Vet Res. 1990;51:165-170.
12. Silverman DJ. Adherence of platelets to human endothelial cells infected by Rickettsia rickettsii. J Infect Dis. 1986;153:694-700.
13. Wilfert CM, MacCormack JN, Kleeman K, et al. Epidemiology of Rocky Mountain spotted fever as determined by active surveillance. J Infect Dis. 1984;150:480-488.
14. Sexton DJ, Corey GR. Rocky Mountain "spotless" and "almost spotless" fever: a wolf in sheep's clothing. Clin Infect Dis. 1992;15:439-448.
15. Myers SA, Sexton DJ. Dermatologic manifestations of artropod-borne diseases. Infect Dis Clin North Am. 1994;8:689-712.
16. Kirkland KB, Wilkinson WE, Sexton DJ. Therapeutic delay and mortality in cases of Rocky Mountain spotted fever. Clin Infect Dis. 1995;20:1118-1121.
17. Woodward TE. Rocky Mountain spotted fever: epidemiological and early clinical signs are keys to treatment and reduced mortality. J Infect Dis. 1984;150:465-468.
18. Weber DJ, Walker DH. Rocky Mountain spotted fever. Infect Dis Clin North Am. 1991;5(1):19-35.
19. Woodward TE. Rocky Mountain spotted fever: a present-day perspective. Medicine. 1992;71:255-259.
20. Kamper C. Treatment of Rocky Mountain spotted fever. J Pediatr Health Care. 1991;5:216-222.
21. Walker DH, Burday MS, Folds JD. Laboratory diagnosis of Rocky Mountain spotted fever. South Med J. 1980;73:1443-1446.
22. Walker DH, Cain BG, Olmsteael PM. Laboratory diagnosis of Rocky Mountain spotted fever by immunofluorescent demonstration of Rickettsia in cutaneous lesion. Am J Clin Pathol. 1978;69:619-623.
23. Dumler JS, Gage WR, Pettis GL, Azad AF, Kuhadja FP. Rapid immunoperoxidase demonstration of Rickettsia rickettsii in fixed cutaneous specimens from with Rocky Mountain spotted fever. Am J Clin Pathol, 1990;93:410-414.
24. White WL, Patrick, JD, Miller LR. Evaluation of immunoperoxidase techniques to detect Rickattsia rickettsii in fixed tissue sections. Am J Clin Pathol. 1994;101:747-752.
25. Wharton M, Chorba TL, Vogt RL, Morse DL, Buehler JW. Case definitions for public health surveillance. MMWR. 1990;39(RR-13)30-31.
26. Iezzoni JC, Manahan LJ, Park C-S, Brigati DJ. Recent advances in automated immunocytochemistiy. J Histotech. 1993;16:39-50.
27. Dawson-Saunders B, Trapp RG. Basic and Clinical Biostatistics, Norwalk, Conn: Appleton & Lange; 1990.
28. Conlon PJ, Procop GW, Fowler V, et al. Predictors of prognosis and risk of acute renal failure in patients with Rocky Mountain spotted fever. Am J Med. 1996:101:621-626.
29. Masu S, Seiji M. Pigmentary incontinence in fixed drug eruptions: histologic and electron microscopic findings. J Am Acad Dermatol, 1983;8:525-532.